|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
956,580,000 |
Market
Cap: |
670.78(B) |
Last
Volume: |
8,218,105 |
Avg
Vol: |
3,360,707 |
52
Week Range: |
$625.65 - $960.02 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : 13 |
Insider 6 Months : 13 |
Insider 3/6 Months : 26.1 |
|
Guru Rank Number : 412 |
Guru Rank Value : 5.2 |
Guru Occurances : 3 |
|
|
|
|
|
|
|
Company Profile Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products, and other therapies. Co.'s diabetes products include: Baqsimi®, Basaglar®, Humalog®, Humulin®, Jardiance®, Lyumjev®, Trajenta®, and Trulicity®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux®, Retevmo®, Tyvyt®, and Verzenio®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta®, Emgality®, Reyvow®, and Zyprexa®. Co.'s other therapies include: Bamlanivimab, Cialis®, and Forteo®.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
2,640 |
2,640 |
2,640 |
2,640 |
Total Buy Value |
$1,708,646 |
$1,708,646 |
$1,708,646 |
$1,708,646 |
Total People Bought |
4 |
4 |
4 |
4 |
Total Buy Transactions |
4 |
4 |
4 |
4 |
Total Shares Sold |
282,250 |
914,054 |
1,217,982 |
4,620,186 |
Total Sell Value |
$226,919,432 |
$2,147,483,647 |
$2,147,483,647 |
$2,147,483,647 |
Total People Sold |
3 |
3 |
4 |
6 |
Total Sell Transactions |
3 |
11 |
19 |
67 |
End Date |
2025-05-18 |
2025-02-14 |
2024-08-16 |
2023-08-17 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Montarce Lucas |
EVP & CFO |
|
2025-08-15 |
4 |
B |
$691.79 |
$494,627 |
D/D |
715 |
14,685 |
2.74 |
- |
|
Alvarez Ralph |
Director |
|
2025-08-13 |
4 |
B |
$660.25 |
$500,473 |
I/I |
758 |
758 |
2.1 |
4% |
|
Fyrwald J Erik |
Director |
|
2025-08-12 |
4 |
B |
$642.00 |
$1,005,242 |
D/D |
1,565 |
74,578 |
2.39 |
7% |
|
Greene Gabrielle E |
Director |
|
2025-08-12 |
4 |
B |
$641.18 |
$75,018 |
D/D |
117 |
2,703 |
2.39 |
7% |
|
Yuffa Ilya |
EVP&Pres, LLY USA&Global Capab |
|
2025-08-11 |
4 |
AS |
$627.01 |
$783,763 |
D/D |
(1,250) |
26,260 |
|
- |
|
Jackson Jamere |
Director |
|
2025-08-08 |
4 |
B |
$639.56 |
$127,913 |
D/D |
200 |
9,402 |
2.39 |
9% |
|
Seymour Melissa |
EVP, Global Quality |
|
2025-08-01 |
4 |
D |
$740.07 |
$315,951 |
D/D |
(427) |
525 |
|
- |
|
Seymour Melissa |
EVP, Global Quality |
|
2025-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
952 |
952 |
|
- |
|
Lilly Endowment Inc |
|
|
2025-07-24 |
4 |
S |
$803.48 |
$225,419,259 |
D/D |
(280,000) |
95,736,978 |
|
15% |
|
Luciano Juan R |
Director |
|
2025-07-21 |
4 |
A |
$762.18 |
$14,834 |
D/D |
19 |
16,382 |
|
- |
|
Fyrwald J Erik |
Director |
|
2025-07-21 |
4 |
A |
$762.18 |
$9,917 |
D/D |
13 |
73,013 |
|
- |
|
Hedley Mary Lynne |
Director |
|
2025-07-21 |
4 |
A |
$762.18 |
$9,917 |
D/D |
13 |
1,973 |
|
- |
|
Alvarez Ralph |
Director |
|
2025-07-21 |
4 |
A |
$762.18 |
$11,750 |
D/D |
15 |
54,995 |
|
- |
|
Greene Gabrielle E |
Director |
|
2025-07-21 |
4 |
A |
$762.18 |
$4,958 |
D/D |
7 |
2,586 |
|
- |
|
Luciano Juan R |
Director |
|
2025-06-16 |
4 |
A |
$807.58 |
$14,834 |
D/D |
18 |
16,362 |
|
- |
|
Hedley Mary Lynne |
Director |
|
2025-06-16 |
4 |
A |
$807.58 |
$9,916 |
D/D |
12 |
1,960 |
|
- |
|
Alvarez Ralph |
Director |
|
2025-06-16 |
4 |
A |
$807.58 |
$11,750 |
D/D |
15 |
54,979 |
|
- |
|
Greene Gabrielle E |
Director |
|
2025-06-16 |
4 |
A |
$807.58 |
$4,959 |
D/D |
6 |
2,580 |
|
- |
|
Fyrwald J Erik |
Director |
|
2025-06-16 |
4 |
A |
$807.58 |
$9,916 |
D/D |
12 |
73,000 |
|
- |
|
Custer Kenneth L. |
EVP & President, Card Met Hlth |
|
2025-06-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,328 |
|
-8% |
|
Zakrowski Donald A |
SVP, Finance, & CAO |
|
2025-05-27 |
4 |
AS |
$716.41 |
$716,410 |
D/D |
(1,000) |
4,840 |
|
-14% |
|
Fyrwald J Erik |
Director |
|
2025-05-19 |
4 |
A |
$755.11 |
$9,917 |
D/D |
13 |
72,852 |
|
- |
|
Hedley Mary Lynne |
Director |
|
2025-05-19 |
4 |
A |
$755.11 |
$9,917 |
D/D |
13 |
1,944 |
|
- |
|
Greene Gabrielle E |
Director |
|
2025-05-19 |
4 |
A |
$755.11 |
$4,958 |
D/D |
7 |
2,569 |
|
- |
|
Luciano Juan R |
Director |
|
2025-05-19 |
4 |
A |
$755.11 |
$14,833 |
D/D |
20 |
16,314 |
|
- |
|
1430 Records found
|
|
Page 1 of 58 |
|
|